Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Arthritis Research & Therapy|June 22, 2022
Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional studySidha Sreedharan, Ning Li, Geoff Littlejohn, et al.
Internal Medicine Journal|March 7, 2020
Who is afraid of biosimilars? Openness to biosimilars in an Australian cohort of patients with rheumatoid arthritisTom Kovitwanichkanont, Sudha Raghunath, Dorothy Wang, et al.
Lupus Science & Medicine|February 24, 2022
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysisMelissa Northcott, Sarah Jones, Rachel Koelmeyer, et al.
Arthritis Research & Therapy|July 15, 2021
Disease course following High Disease Activity Status revealed patterns in SLEAlberta Hoi, Rachel Koelmeyer, Julie Bonin, et al.
Lupus Science & Medicine|May 30, 2020
High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosusRachel Koelmeyer, Hieu Tri Nim, Mandana Nikpour, et al.
International Journal of Rheumatic Diseases|May 17, 2021
Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statementsKenji Oku, Laniyati Hamijoyo, Nuntana Kasitanon, et al.
The American Journal of Pathology|December 26, 2003
Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant miceYuan H Yang, Pam Hall, Georgia Milenkovski, et al.
Internal Medicine Journal|June 17, 2021
Impact of COVID-19 telehealth on outpatient test completionTong Lei Liu, Ai Li Yeo, Ayngaran Ravi, et al.
Internal Medicine Journal|January 10, 2018
Acceptability of opt-out consent in a hospital patient populationDaniel Boulos, Eric Morand, Michelle Foo, et al.
RMD Open|April 24, 2025
Outcomes of patients with systemic lupus erythematosus treated with belimumab: a post hoc efficacy analysis of five phase III clinical trials by British Isles Lupus Assessment Group-based Combined Lupus Assessment criteriaIoannis Parodis, Julius Lindblom, Leonardo Palazzo, et al.
Pageof 8